07/03/2024 4:27 PM | Arrowhead Pharmaceuticals (Issuer) Oliver Tracie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 3:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024 5:04 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 1:39 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 1:03 PM | Arrowhead Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/03/2024 5:05 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 3:30 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/20/2024 6:06 PM | Arrowhead Pharmaceuticals (Issuer) Lu Hongbo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 3:38 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 6:00 PM | Arrowhead Pharmaceuticals (Issuer) Lu Hongbo (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/08/2024 4:54 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:30 PM | Arrowhead Pharmaceuticals (Subject) Myszkowski Kenneth Allen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 4:25 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:57 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024 4:28 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEFA14A | |
01/24/2024 11:57 AM | Arrowhead Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024 3:14 PM | Arrowhead Pharmaceuticals (Subject) BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/17/2024 5:32 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:22 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144/A | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Ferrari Mauro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 5:06 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:48 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024 3:38 PM | Arrowhead Pharmaceuticals (Subject) Arrowhead Pharmaceuticals (Subject) Waddill William D. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024 3:22 PM | Arrowhead Pharmaceuticals (Subject) Ferrari Mauro (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 4:16 PM | Arrowhead Pharmaceuticals (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:16 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:17 PM | Arrowhead Pharmaceuticals (Issuer) Oliver Tracie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 6:58 PM | Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 7:02 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 4:33 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 4:14 PM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:39 PM | Arrowhead Pharmaceuticals (Subject) Myszkowski Kenneth Allen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:21 PM | Arrowhead Pharmaceuticals (Subject) San Martin Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024 3:08 PM | Arrowhead Pharmaceuticals (Subject) Oliver Tracie (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 4:25 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 4:27 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 12:49 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 12:06 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024 12:25 PM | Arrowhead Pharmaceuticals (Subject) O'Brien Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The death of Nvidia? (Ad) Today, I’m warning of another looming catastrophe.
Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out.
You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy...
There's also no escaping that The Big AI Die-Up is coming.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9247&Placement=NativeDisplay&Source=NativeDisplay) So go here now to read my new report The Big AI Die-Up… while you still can. |
01/04/2024 11:24 AM | Arrowhead Pharmaceuticals (Subject) Hamilton James C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024 3:44 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 4:04 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 3:34 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023 2:51 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:52 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:54 PM | Arrowhead Pharmaceuticals (Issuer) OLUKOTUN ADEOYE Y (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:55 PM | Arrowhead Pharmaceuticals (Issuer) PERRY MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 2:41 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:16 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/29/2023 3:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 1:31 PM | Arrowhead Pharmaceuticals (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/27/2023 5:23 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:51 PM | Arrowhead Pharmaceuticals (Issuer) Vakiener Victoria (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 1:50 PM | Arrowhead Pharmaceuticals (Subject) Vakiener Victoria (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 5:10 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:20 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |